REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dizal (Jiangsu) Pharmaceutical Co., Ltd. Profile Updated: December 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Dizal (Jiangsu) Pharmaceutical Co., Ltd. focuses on the exploration, R&D and commercialization of innovative drugs. The company conducts new drug research in major diseases such as malignant tumors, immune diseases and kidney diseases. The company was founded in 2017 and headquartered in Wuxi City, China.

Headquarters
Building 4, No. 199, 245 Liangjing Road, Pudong New Area Pilot Free Trade Zone, Shanghai
Wuxi; Jiangsu; Postal Code: 214135;201203

Contact Details: Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) report to view the information.

Website: http://www.dizalpharma.com

Basic Information
Total Employees:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) report to view the information.
Registered Capital:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) report to view the information.
Financial Auditors:
Purchase the Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) report to view the information.
Incorporation Date:
October 27, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
23.71%
Purchase this report to view the information.
23.71%
Purchase this report to view the information.
12.51%
Purchase this report to view the information.
1.65%
Purchase this report to view the information.
1.47%
Subsidiaries
Dizhe (Beijing) Pharmaceutical Co., Ltd.
100%
Dizhe (Shanghai) Pharmaceutical Co., Ltd.
100%
Dizhe (Wuxi) Pharmaceutical Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Dizal (Jiangsu) Pharmaceutical Co., Ltd. (迪哲(江苏)医药股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
73.23%▲
Total operating revenue
73.12%▲
Operating profit (EBIT)
10.47%▲
Net Profit (Loss) for the Period
10.27%▲
Total assets
79.93%▲
Total equity
230.19%▲
Operating Profit Margin (ROS)
92.94%▲
Net Profit Margin
92.52%▲
Return on Equity (ROE)
108.2%▲
Debt to Equity Ratio
-127.86%▼
Quick Ratio
0.76%▲
Cash Ratio
0.95%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Lionco Pharmaceutical Group Co.,Ltd.
 
Chengda Pharmaceuticals Co.,Ltd.
Lepu Biopharma Company Limited
 
Hua Medicine (Shanghai) (华领医药 (上海))
Jiangsu Bioperfectus Technologies Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo